Cargando…
Moving things forward in Hodgkin lymphoma
Arising from the immune system and located primarily in lymphoid organs, Hodgkin lymphoma (HL) is one of the most common cancers in young adults. Risk-adapted first-line treatment usually consisting of multi-agent chemotherapy and often incorporating consolidative radiation therapy aims at long-term...
Autores principales: | Bröckelmann, Paul J., Böll, Boris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234718/ https://www.ncbi.nlm.nih.gov/pubmed/30473768 http://dx.doi.org/10.12688/f1000research.16077.1 |
Ejemplares similares
-
Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma
por: Amadori, Dino
Publicado: (2011) -
P038: HLA expression patterns of Hodgkin-Reed-Sternberg cells shape a spatially arranged tumor microenvironment in classical Hodgkin lymphoma
por: Müller-Meinhard, Berit, et al.
Publicado: (2022) -
Cancer epigenetics: Moving forward
por: Nebbioso, Angela, et al.
Publicado: (2018) -
Moving forward in the treatment of cholangiocarcinoma
por: Manzia, Tommaso M, et al.
Publicado: (2021) -
Graves’ disease: moving forwards
por: Lane, Laura C, et al.
Publicado: (2023)